Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe
- PMID: 16274744
- DOI: 10.1016/j.jinf.2005.09.015
Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe
Abstract
We present a 42-year-old man who was admitted with worsening of his general condition and facial skin lesions. He had previously been diagnosed with HIV infection and visceral leishmaniasis (VL). Diagnostic work-up revealed a new relapse of VL paralleled by the diagnosis of post-kala-azar dermal leishmaniasis (PKDL). The patient was treated with IV liposomal amphotericin B as well as sodium stibogluconate followed by oral hexadecylphosphocholine (miltefosine) over a period of 9 months. PKDL lesions began to disappear after 8 months of treatment. In addition, severe and relapsing VL so far remains in remission. This case demonstrates successful treatment of PKDL and relapsing VL in a Western European patient with HIV infection.
Similar articles
-
Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.Am J Trop Med Hyg. 2009 Mar;80(3):336-8. Am J Trop Med Hyg. 2009. PMID: 19270277
-
Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.Trans R Soc Trop Med Hyg. 2006 Jul;100(7):698-700. doi: 10.1016/j.trstmh.2005.09.015. Epub 2005 Dec 2. Trans R Soc Trop Med Hyg. 2006. PMID: 16325873
-
Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.Am J Trop Med Hyg. 2008 Nov;79(5):715-8. Am J Trop Med Hyg. 2008. PMID: 18981510
-
Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.Br J Dermatol. 2007 Nov;157(5):1032-6. doi: 10.1111/j.1365-2133.2007.08157.x. Epub 2007 Sep 13. Br J Dermatol. 2007. PMID: 17854365 Review.
-
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.J Assoc Physicians India. 2003 Jul;51:686-90. J Assoc Physicians India. 2003. PMID: 14621038 Review.
Cited by
-
The relationship between leishmaniasis and AIDS: the second 10 years.Clin Microbiol Rev. 2008 Apr;21(2):334-59, table of contents. doi: 10.1128/CMR.00061-07. Clin Microbiol Rev. 2008. PMID: 18400800 Free PMC article. Review.
-
Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.Am J Trop Med Hyg. 2011 Jun;84(6):906-12. doi: 10.4269/ajtmh.2011.11-0055. Am J Trop Med Hyg. 2011. PMID: 21633027 Free PMC article.
-
PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3258. doi: 10.1371/journal.pntd.0003258. eCollection 2014. PLoS Negl Trop Dis. 2014. PMID: 25412435 Free PMC article. Review.
-
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis.Case Rep Infect Dis. 2014;2014:370286. doi: 10.1155/2014/370286. Epub 2014 Aug 14. Case Rep Infect Dis. 2014. PMID: 25197584 Free PMC article.
-
Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol.BMJ Open. 2016 May 17;6(5):e010050. doi: 10.1136/bmjopen-2015-010050. BMJ Open. 2016. PMID: 27188804 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical